
Role of VEGF and CD44v6 in differentiating benign from malignant ascites
Author(s) -
Weiguo Dong,
Xiaomin Sun,
Bingqing Yu,
Hao Luo,
Jie-Ping Yu
Publication year - 2003
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v9.i11.2596
Subject(s) - ascites , medicine , gastroenterology , vascular endothelial growth factor , ovarian cancer , cancer , pathology , vegf receptors
To detect the vascular endothelial growth factor (VEGF) and soluble splice variant 6 of CD44 (sCD44v6) levels in ascites and to explore their role in differentiating benign from malignant ascites.